ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "radiography and rheumatoid arthritis (RA)"

  • Abstract Number: 2137 • 2014 ACR/ARHP Annual Meeting

    Linear Extrapolation of Missing Radiographic Progression Scores Does Not Spuriously overestimate overall Radiographic Progression in Rheumatoid Arthritis

    Iris Markusse1, Robert Landewé2,3, Meilien Ho4, Martin Jenkins4 and Desiree van der Heijde5, 1Leiden University Medical Center, Leiden, Netherlands, 2Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 3Atrium Medical Center, Heerlen, Netherlands, 4AstraZeneca R&D Alderley Park, Macclesfield, United Kingdom, 5Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose : Linear Extrapolation (LE) is a frequently applied method to impute missing radiographic data in trials. However, there is frequent critique that LE overestimates…
  • Abstract Number: 1890 • 2014 ACR/ARHP Annual Meeting

    Consistent Inhibition of Bone Destruction By Denosumab in Important Subgroups of Japanese Patients with Rheumatoid Arthritis

    Naoki Ishiguro1, Yoshiya Tanaka2, Hisashi Yamanaka3, Toshiyuki Yoneda4, Takeshi Ohira5, Naoki Okubo6, Harry K. Genant7, Desiree van der Heijde8 and Tsutomu Takeuchi9, 1Orthopaedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Japan, 2University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 3Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, 4Indiana University School of Medicine, Indianapolis, IN, 5Daiich Sankyo Co. Ltd, Tokyo, Japan, 61-2-58, Hiromachi, Daiichi Sankyo Co. Ltd, Tokyo, Japan, 7University of California, San Francisco, CCBR-Synarc, Newark, Tiburon, CA, 8Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 9Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

    Background/Purpose Denosumab is a fully human monoclonal antibody (IgG2 subclass) that binds specifically to RANKL, inhibits osteoclast-induced bone resorption by preventing the binding of RANKL…
  • Abstract Number: 1474 • 2014 ACR/ARHP Annual Meeting

    Anti-Peptidyl Arginine Deiminase 4 Antibodies in African-Americans with Rheumatoid Arthritis and  Radiographic Scores

    Iris Navarro-Millan1, Andrew Westfall2, Erika Darrah3,4, Antony Rosen5, Ted R. Mikuls6, Richard Reynolds2, Maria I. Danila7, Jeffrey R. Curtis2 and S. Louis Bridges Jr.2,8, 1Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3Division of Rheumatology, The Johns Hopkins University, Baltimore, MD, 45200 Eastern Ave MFL Bldg Cntr, The Johns Hopkins University, Division of Rheumatology, Baltimore, MD, 5Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 6Veteran Affairs Nebraska Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, 7Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 8Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: The presence of serum autoantibodies to peptidyl arginine deiminase 4 (PAD4) have been associated with erosive rheumatoid arthritis (RA) in populations that were composed…
  • Abstract Number: 1431 • 2014 ACR/ARHP Annual Meeting

    Influence of Radiographic Joint Damage in Mortality Risk in a Cohort of Rheumatoid Arthritis Patients: A 20 Years Survival Study

    L. Rodriguez-Rodriguez1,2, J. Ivorra-Cortes3, Lydia Abasolo1,4, Leticia Leon1,4, Oscar Fontsere5, B. Fernández-Gutiérrez1,5 and Juan A Jover1,4, 1Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain, 2Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, 3Rheumatology, University Hospital la Fe, Valencia, Spain, 4Rheumatology, Hospital Clinico San Carlos, Madrid, Spain, 5Rheumatology, Hospital Clínico San Carlos, Madrid, Spain

    Background/Purpose Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increased mortality and reduced life expectancy compared with the general population. This mortality gap…
  • Abstract Number: 1387 • 2014 ACR/ARHP Annual Meeting

    Radiographic Progression Differs Between Trajectory Clusters Defined By DAS28 Scores in Early Rheumatoid Arthritis

    Cheryl Barnabe1, Ye Sun2, Gilles Boire3, Carol Hitchon4, Edward C. Keystone5, J. Carter Thorne6, Boulos Haraoui7, Jeffrey R. Curtis8, Désirée van der Heijde9, Diane Tin10, Janet E. Pope11 and Vivian P. Bykerk12, 1Division of Rheumatology, University of Calgary, Calgary, AB, Canada, 2Mount Sinai Hospital, Toronto, ON, Canada, 3Rheumatology Division, CHUS - Sherbrooke University, Sherbrooke, QC, Canada, 4Rheumatology, University of Manitoba, Winnipeg, MB, Canada, 5Medicine, University of Toronto, Toronto, ON, Canada, 6Southlake Regional Health Centre, Newmarket, Newmarket, ON, Canada, 7Department of Medicine, Centre Hospitalier de l’Université de Montréal, Montréal, QC, Canada, 8The University of Alabama at Birmingham, Birmingham, AL, 9Rheumatology, Leiden University Medical Ctr, Leiden, Netherlands, 10The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 11Medicine, Western University, London, ON, Canada, 12Rheumatology, Hospital for Special Surgery, New York, NY

    Background/Purpose: Group-based trajectory modeling defines clusters of individuals in observed data with similar disease trajectories. We have previously defined five distinct trajectories in early rheumatoid…
  • Abstract Number: 1365 • 2014 ACR/ARHP Annual Meeting

    ARE Erosions a Disappearing Feature in Rheumatoid Arthritis (RA)?Joint Damage in Patients with EARLY RA at 10 YEARS after Diagnosis

    Juha Asikainen1, Kalevi Kaarela2, Heidi Mäkinen3, Hannu Kautiainen4, Pekka Hannonen5, Tuomas Rannio6 and Tuulikki Sokka1, 1Jyvaskyla Central Hospital, Jyväskylä, Finland, 2Jyväskylä Central Hospital, Jyväskylä, Finland, 3Tampere University Hospital, Tampere, Finland, 4Medcare Oy, Äänekoski, Finland, 5Jyväskylä Central Hospital, Jyvaskyla, Finland, 6Kuopio University Hospital, Kuopio, Finland

    Background/Purpose: Treatment of rheumatoid arthritis (RA) has improved during the last decade. Also importance of regular monitoring has been emphasized. Our objective was to study…
  • Abstract Number: 840 • 2014 ACR/ARHP Annual Meeting

    Vascular Calcifications on Hand and Wrist Radiographs Are Associated with Cardiovascular Risk Factors, Antigen-Specific Anti-Citrullinated Protein Antibodies, and Mortality in Rheumatoid Arthritis

    E. Blair Solow1, Fang Yu2, Geoffrey M. Thiele3, Jeremy Sokolove4,5, William H. Robinson6,7, Zachary M. Pruhs3, Kaleb Michaud8,9, Alan R. Erickson9, Harlan Sayles9, Gail S. Kerr10, Angelo L. Gaffo11, Liron Caplan12, Lisa A. Davis13, Grant W. Cannon14, Andreas M. Reimold15, Joshua Baker16, Pascale Schwab17,18, Daniel Anderson9 and Ted R. Mikuls9, 1Internal Medicine, Division of Rheumatic Diseases, UT Southwestern Medical Center, Dallas, TX, 2University of Nebraska Medical Center, Omaha, NE, 3Internal Medicine, Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 4VA Palo Alto Healthcare System and Stanford University, Palo Alto, CA, 5Stanford University School of Medicine, Stanford, CA, 6VA Palo Alto Health Care System and Stanford University, Palo Alto, CA, 7Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 8National Data Bank for Rheumatic Diseases, Wichita, KS, 9Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 10Rheumatology, Washington DC VAMC, Georgetown and Howard University, Washington, DC, 11Medicine, Birmingham VA Medical Center and University of Alabama at Birmingham, Birmingham, AL, 12Div of Rheumatology, Denver VAMC and Univ of Colorado School of Medicine, Aurora, CO, 13Denver VAMC and Univ of Colorado School of Medicine, Aurora, CO, 14Division of Rheumatology, Salt Lake City VA and University of Utah, Salt Lake City, UT, 15Rheumatology, Dallas VA and University of Texas Southwestern, Dallas, TX, 16Medicine/Rheumatology, University of Pennsylvania and Philadelphia VAMC, Philadelphia, PA, 17Department of Internal Medicine, Division of Rheumatology, Portland VA Medical Center, Portland, OR, 18Internal Medicine, Division of Arthritis & Rheumatic Diseases, Oregon Health & Science University, Portland, OR

    Background/Purpose:   Rheumatoid arthritis (RA) is associated with increased mortality due to cardiovascular disease (CVD).  Select antigen-specific anti-citrullinated protein antibodies (ACPA) are associated with atherosclerotic…
  • Abstract Number: 393 • 2014 ACR/ARHP Annual Meeting

    Influence of Body Mass Index on Disease Activity and Radiographic Joint Damage in Rheumatoid Arthritis : A Systematic Review and Meta-Analysis

    Celine Vidal1, Thomas Barnetche2, Jacques Morel3, Bernard Combe4 and Claire Daien5, 1Rheumatology, Hopital Lapeyronie, Montpellier, France, 2rheumatology, Rheumatology department, Bordeaux University Hospital, bordeaux, France, 3Department of Rheumatology, Hôpital Lapeyronie, Montpellier, France, 4Immuno-Rhumatologie, Hôpital Lapeyronie, Montpellier, France, 5Hopital Lapeyronie, Montpellier, France

    Background/Purpose: Overweight and obesity in patients with rheumatoid arthritis (RA) are rising conditions. Adipose tissue has pro inflammatory properties by producing adipokines which could play…
  • Abstract Number: 364 • 2014 ACR/ARHP Annual Meeting

    In Early Rheumatoid Arthritis, the Multi-Biomarker Disease Activity Score at Different Time-Points Is Predictive of Subsequent Radiographic Progression

    Karen Hambardzumyan1, R.J. Bolce2, Saedis Saevarsdottir*3, Kristina Forslind4, Ingemar F. Petersson5, Pierre Geborek6, Eric H. Sasso2, David Chernoff2, Scott Cruickshank7 and Ronald F. van Vollenhoven8, 1ClinTRID, the Karolinska Institute, Stockholm, Sweden, 2Crescendo Bioscience Inc., South San Francisco, CA, 3Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 4Department of Medicine, Karolinska Institute, Stockholm, Sweden, 5Lund University, Lund, Sweden, 6Section of Rheumatology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden, 7Scott Cruickshank and Associates, Inc., Santa Barbara, CA, 8Unit for clinical therapy research (ClinTrid), Karolinska Institute, Stockholm, Sweden

    Background/Purpose The prediction of radiographic progression in early rheumatoid arthritis (eRA) patients is important for optimal treatment. We previously demonstrated that a multi-biomarker disease activity…
  • Abstract Number: 2973 • 2014 ACR/ARHP Annual Meeting

    The Multi-Biomarker Disease Activity Score As a Predictor of Radiographic Progression in a Registry of Patients with Rheumatoid Arthritis

    Eric H. Sasso1, George Wu2, CC Hwang2, Michael E. Weinblatt3, Nancy A. Shadick4, Claire Alexander5 and Oscar Segurado1, 1Crescendo Bioscience Inc., South San Francisco, CA, 2Biostatistics, Crescendo Bioscience Inc., South San Francisco, CA, 3Division of Rheumatology & Immunology, Brigham and Women's Hospital, Boston, MA, 4Rheumatology/Immunology, Brigham and Women's Hospital, Boston, MA, 5Clinical Operations, Crescendo Bioscience Inc., South San Francisco, CA

    Background/Purpose This study evaluated the association between baseline disease activity, as assessed with the multi-biomarker disease activity (MBDA) blood test, CRP or clinical measures, and…
  • Abstract Number: 2883 • 2013 ACR/ARHP Annual Meeting

    Clinical Characteristics of Rheumatoid Arthritis Patients with Secondary Sjögren’s Syndrome and Association with Joint Damage

    Lindsay E. Brown1, Michelle A. Frits2, Christine K. Iannaccone2, Michael E. Weinblatt2, Nancy A. Shadick3 and Katherine P. Liao4, 1Internal Medicine, Massachusetts General Hospital, Boston, MA, 2Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 3Rheumatology/Immunology, Brigham and Women's Hospital, Boston, MA, 4Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Secondary Sjögren's syndrome (sSS) is a common extra-articular manifestation of rheumatoid arthritis (RA).  However, the clinical characteristics of this subgroup of patients are not…
  • Abstract Number: 2379 • 2013 ACR/ARHP Annual Meeting

    In Rheumatoid Arthritis Patients With Stable Low Disease Activity On Methotrexate Plus Etanercept, Continuation Of Etanercept Is Superior Both Clinically and Radiographically To Discontinuation: Results From a Randomized, 3-Armed, Double-Blind Clinical Trial

    Mikkel Østergaard1, Marjatta Leirisalo-Repo2, Till Uhlig3, Marita Jansson4, Esbjörn Larsson4, Fiona Brock5 and Ronald F. van Vollenhoven6, 1Copenhagen University Hospital Glostrup, Copenhagen, Denmark, 2Department of Medicine, Division of Rheumatology, Helsinki University Central Hospital, Helsinki, Finland, 3Diakonhjemmet Hospital, Oslo, Norway, 4Pfizer AB, Sollentuna, Sweden, 5Quanticate, Hitchin, Hertfordshire, United Kingdom, 6Clinical Trials Unit Department of Rheumatology, The Karolinska Institute, Stockholm, Sweden

    Background/Purpose: The randomized clinical trial “DOSERA” has shown that in patients receiving concomitant methotrexate (MTX) therapy, continuation of etanercept (ETN) at 50 mg wkly is…
  • Abstract Number: 1957 • 2013 ACR/ARHP Annual Meeting

    Correlation Of Structural Abnormalities Of The Wrist and Metacarpophalangeal Joints Evaluated By High-Resolution Peripheral Quantitative Computed Tomography, 3 Tesla MRI and Conventional Radiographs In Rheumatoid Arthritis

    Chan Hee Lee1,2, Waraporn Srikhum2,3, Andrew J. Burghardt4, Warapat Virayavanich2,5, Thomas M. Link2, John B. Imboden6 and Xiaojuan Li7, 1Div Rheum Dept of Intl Med, NHIC Ilsan Hospital, Goyang-si, South Korea, 2Musculoskeletal Quantitative Imaging Research Group, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, 3Department of Radiology, Thammasat University, Pathumthani, Thailand, 4Department of Radiology & Biomedical Imaging, Musculoskeletal Quantitative Imaging Research, UCSF, San Francisco, CA, 5Department of Radiology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, 6Department of Medicine, Division of Rheumatology, UCSF, San Francisco, CA, 7Department of Radiology and Biomedical Imaging, Musculoskeletal Quantitative Imaging Research, UCSF, San Francisco, CA

    Background/Purpose: Early detection of joint inflammation and tissue damage are critical for patient management in rheumatoid arthritis (RA). High-resolution peripheral quantitative computed tomography (HR-pQCT) is…
  • Abstract Number: 1968 • 2013 ACR/ARHP Annual Meeting

    A Novel, Feasible and Reliable Method Of Radiographic Scoring Of Rheumatoid Arthritis

    Priyanka Vashisht1, Harlan Sayles2, Ted R. Mikuls2 and Alan R. Erickson2, 1Creighton University Medical Center, Omaha, NE, 2Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Radiographs of the hands and feet are used to evaluate the disease course of rheumatoid arthritis (RA) with several scoring systems previously described. However,…
  • Abstract Number: 1457 • 2013 ACR/ARHP Annual Meeting

    Inhibitory Effect Of Abatacept On Joint Damage In Rheumatoid Arthritis Patients With Or Without Concomitant Methotrexate: A Retrospective Multicenter Analysis Of 12 Months Of Abatacept Treatment In Routine Clinical Practice

    Isao Matsushita1, Hiraku Motomura1, Eiko Seki1 and Tomoatsu Kimura2, 1Department of Orthopaedic Surgery, Faculty of Medicine, University of Toyama, Toyama, Japan, 2Department of rthopaedic Surgery, Faculty of Medicine, University of Toyama, Toyama, Japan

    Background/Purpose: Abatacept is approved for use with or without methotrexate (MTX). The purpose of this study was to clarify the inhibitory effect of abatacept on…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology